Advertise with Us

Latest Issue

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events

Expo

Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Advertise with Us

BIO-RAD LABORATORIES

EUROIMMUN AG

Absology

ABSOLOGY is a medical equipment manufacturer that develops and mass-produces in vitro diagnostic medical devices. ABS... read more Featured Products:

NT-proBNP Diagnostic Test

C-Reactive Protein Diagnostic Test

Procalcitonin Diagnostic Test

POC Immunoassay System

Troponin I, NT-proBNP & CK-MB Combo Test

More products

ELITechGroup SAS

DIASYS DIAGNOSTIC SYSTEMS

Download Mobile App

Featured Video

ADLM:
ADLM 2024 –Connect with the Greatest Minds in Laboratory Medicine

GLOBETECH PUBLISHING LLC

Absology Exhibits POCT Immunoassay Analyzer with Testing Time of Five Minutes

By LabMedica International staff writers
Posted on 16 Nov 2022

Image: The ABSOL POCT immunoassay system is on display at MEDICA 2022 (Photo courtesy of Absology)

Image: The ABSOL POCT immunoassay system is on display at MEDICA 2022 (Photo courtesy of Absology)

Absology Co., Ltd. (Gyeonggi-do, Korea) is participating in MEDICA 2022 where the company is exhibiting its POC FIA (Fluorescence Immunoassay) analyzer that uses microfluidic technology for the accurate quantitative diagnosis of concentration of biomarkers for a range of diseases.

At MEDICA 2022, Absology is showcasing its ABSOL POCT analyzer that uses FIA technology to quantitatively diagnose the concentration of biomarkers. It has a test time of only five minutes and features a vivid expressed GUI along with a convenient built-in printer. Alongside ABSOL, the company is showcasing the ABSOL HS high-sensitive ELISA analyzer for early disease screening. ABSOL HS can detect Femtogram level molecules using Absology’s proprietary PIFA (Photooxidation Induced Fluorescence Amplification) technology. It has a test time of only 30 minutes and requires just 20uL of blood sample. Compact and affordable, the portable and light weight ABSOL HS is a flexible platform for any kind of ELISA protocol. Absology offers a wide test menu for the ABSOL and ABSOL HS systems, including PSA, Testosterone, Vitamin D, TSH, FreeT4, Thyroid Combo, Cortisol, PCT, COVID-19 IgM/IgG, COVID-19 Ag, COVID-19 Neutralizing Antibody, and Influenza A/B.

Related Links:
Absology Co., Ltd.

Visit expo >

Platinum Member

COVID-19 Rapid Test

OSOM COVID-19 Antigen Rapid Test

Magnetic Bead Separation Modules
MAG and HEATMAG

Anti-Cyclic Citrullinated Peptide Test

GPP-100 Anti-CCP Kit

Gold Member

ADAMTS-13 Protease Activity Test

ATS-13 Activity Assay

Latest MEDICA 2022 News

Channels

Clinical Chemistry

view channel

Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases

The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read more

Image: The microfluidic open interface system (Photo courtesy of University of Waterloo)

New Blood Testing Method Detects Potent Opioids in Under Three Minutes

Fentanyl, an opioid 50 times more potent than heroin, presents a major risk to public health. In recent years, there's been a growing concern over the rise in fentanyl use among drug users.... Read more

Molecular Diagnostics

view channel

Blood Proteins Could Warn of Cancer Seven Years before Diagnosis

Two studies have identified proteins in the blood that could potentially alert individuals to the presence of cancer more than seven years before the disease is clinically diagnosed. Researchers found... Read more

Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells

Ultrasound imaging serves as a noninvasive method to locate and monitor cancerous tumors effectively. However, crucial details about the cancer, such as the specific types of cells and genetic mutations... Read more

New DNA Origami Technique to Advance Disease Diagnosis

DNA origami is a method used to create nanostructures with exceptional precision, utilizing DNA strands as the foundational building blocks. These structures, however, are inherently fragile and prone... Read more

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel

Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Image: The Procleix ArboPlex Assay has received the CE mark (Photo courtesy of Grifols)

First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections

Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more

Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Immunology

view channel

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell

Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more

Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel

Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB)

Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections

Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Image: The clinical decision support software differentiates between viral and bacterial infections (Photo courtesy of Smart Blood Analytics)

Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle

Antimicrobial resistance (AMR) is a serious global public health concern that claims millions of lives every year. It primarily results from the inappropriate and excessive use of antibiotics, which reduces... Read more

Pathology

view channel

Image: Images of invasive ductal carcinoma, mucinous carcinoma, and papillary carcinoma (Photo courtesy of Science China Press)

AI Integrated With Optical Imaging Technology Enables Rapid Intraoperative Diagnosis

Rapid and accurate intraoperative diagnosis is essential for tumor surgery as it guides surgical decisions with precision. Traditional intraoperative assessments, such as frozen sections based on H&E... Read more

Image: Roche Cell Collection Medium provides long-term stability for specimens collected via self-collection (Photo courtesy of Roche)

HPV Self-Collection Solution Improves Access to Cervical Cancer Testing

Annually, over 604,000 women across the world are diagnosed with cervical cancer, and about 342,000 die from this disease, which is preventable and primarily caused by the Human Papillomavirus (HPV).... Read more

Hyperspectral Dark-Field Microscopy Enables Rapid and Accurate Identification of Cancerous Tissues

Breast cancer remains a major cause of cancer-related mortality among women. Breast-conserving surgery (BCS), also known as lumpectomy, is the removal of the cancerous lump and a small margin of surrounding tissue.... Read more

Image: Tripath (far right) outperforms current clinical baseline (far left) and 2D deep learning baselines (middle) in cancer recurrence risk prediction (Photo courtesy of Mass General Brigham)

AI Advancements Enable Leap into 3D Pathology

Human tissue is complex, intricate, and naturally three-dimensional. However, the thin two-dimensional tissue slices commonly used by pathologists to diagnose diseases provide only a limited view of the... Read more

Technology

view channel

Image: The nanopore optofluidic chip used in the new diagnostic system (Photo courtesy of UC Santa Cruz)

New Diagnostic System Achieves PCR Testing Accuracy

While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more

Image: The electrochemical sensor detects HPV-16 and HPV-18 with high specificity (Photo courtesy of 123RF)

DNA Biosensor Enables Early Diagnosis of Cervical Cancer

Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more

Image: The self-heating microfluidic devices can help detect diseases without expensive lab equipment (Photo courtesy of MIT)

Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples

Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more

Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible

Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read more

Industry

view channel

Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis

Unlike severe traumatic brain injury (TBI), mild TBI often does not show clear correlations with abnormalities detected through head computed tomography (CT) scans. Consequently, there is a pressing need... Read more

Image: Beckman Coulter is now an authorized distributor of the MeMed Key immunoassay system and MeMed BV assay (Photo courtesy of Beckman Coulter)

Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership

Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed... Read more

Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)

Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe

Thermo Fisher Scientific (Waltham, MA USA) has entered into a strategic distribution agreement with Bio-Techne Corporation (Minneapolis, MN, USA), resulting in a significant collaboration between two industry... Read more

ECCMID Congress Name Changes to ESCMID Global

Over the last few years, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID, Basel, Switzerland) has evolved remarkably. The society is now stronger and broader than ever before... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica Expo HospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2024
Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA

AACC ECCMID EUROMEDLAB Medlab 2021
Medica AACC MEDLAB 2020
AACC

Copyright © 2000-2024 Globetech Media. All rights reserved.

MOBILE | FULL SITE